3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 973-980

  Couturier, Jérôme Y ^a   Ding Zhou, Li ^a   Croci, Nicole ^a   Plotkine, Michel ^a   Margaill, Isabelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

3 Aminobenzamide; Inflammation; Myeloperoxidase; Neutrophil; Poly(ADP ribose) polymerase; Transient focal cerebral ischemia

Indexed keywords

3 AMINOBENZAMIDE; CHLORAL HYDRATE; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; DOSE RESPONSE; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SUTURE;

EID: 0842277725     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00367-4     Document Type: Article

References (54)

1. Affar el B., Shah R.G., Dallaire A.K., Castonguay V., Shah G.M. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Proc. Natl. Acad. Sci. U. S. A. 99:2002;245-250.
2. Banasik M., Komura H., Shimoyama M., Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J. Biol. Chem. 267:1992;1569-1575.
3. Barone F.C., Hillegass L.M., Price W.J., White R.F., Lee E.V., Feuerstein G.Z., Sarau H.M., Clark R.K., Griswold D.E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29:1991;336-345.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
5. Berger N.A. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101:1985;4-15.
6. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:1982;206-209.
7. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. BioEssays. 23:2001;795-806.
8. Chen J., Jin K., Chen M., Pei W., Kawaguchi K., Greenberg D.A., Simon R.P. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J. Neurochem. 69:1997;232-245.
9. Chiarugi A. Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol. Sci. 23:2002;122-129.
10. Cosi C., Chopin P., Marien M. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse. Brain Res. 735:1996;343-348.
11. Cuzzocrea S., Zingarelli B., Costantino G., Szabo A., Salzman A.L., Caputi A.P., Szabo C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121:1997;1065-1074.
12. Cuzzocrea S., Zingarelli B., Gilad E., Hake P., Salzman A.L., Szabo C. Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur. J. Pharmacol. 342:1998;67-76.
13. Ding Y., Zhou Y., Lai Q., Li J., Gordon V., Diaz F.G. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment. Brain Res. 915:2001;210-217.
14. Ding-Zhou L., Marchand-Verrecchia C., Croci N., Plotkine M., Margaill I. L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice. Eur. J. Pharmacol. 457:2002;137-146.
15. Ducrocq S., Benjelloun N., Plotkine M., Ben-Ari Y., Charriaut-Marlangue C. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J. Neurochem. 74:2000;2504-2511.
16. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3:1997;1089-1095.
17. Endres M., Wang Z.Q., Namura S., Waeber C., Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1997;1143-1151.
18. Endres M., Scott G.S., Salzman A.L., Kun E., Moskowitz M.A., Szabo C. Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. Eur. J. Pharmacol. 351:1998;377-382.
19. Feng Y., LeBlanc M.H. Drug-induced hypothermia begun 5 minutes after injury with a poly(adenosine 5′-diphosphate-ribose) polymerase inhibitor reduces hypoxic brain injury in rat pups. Crit. Care Med. 30:2002;2420-2424.
20. Golanov E.V., Reis D.J. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab. 15:1995;172-174.
21. Goto S., Xue R., Sugo N., Sawada M., Blizzard K.K., Poitras M.F., Johns D.C., Dawson T.M., Dawson V.L., Crain B.J., Traystman R.J., Mori S., Hurn P.D. Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke. 33:2002;1101-1106.
22. Ha H.C., Hester L.D., Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3270-3275.
23. Hall E.D. High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J. Neurosurg. 62:1985;882-887.
24. Hassa P.O., Hottiger M.O. A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380:1999;953-959.
25. Hassa P.O., Covic M., Hasan S., Imhof R., Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276:2001;45588-45597.
26. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
27. Jean W.C., Spellman S.R., Nussbaum E.S., Low W.C. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery. 43:1998;1382-1396. (discussion 1396-1397).
28. Jijon H.B., Churchill T., Malfair D., Wessler A., Jewell L.D., Parsons H.G., Madsen K.L. Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am. J. Physiol.: Gastrointest. Liver Physiol. 279:2000;G641-G651.
29. Le Page C., Sanceau J., Drapier J.C., Wietzerbin J. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem. Biophys. Res. Commun. 243:1998;451-457.
30. Lo E.H., Bosque-Hamilton P., Meng W. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D- aspartate-induced neurotransmitter dysregulation. Stroke. 29:1998;830-836.
31. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
32. Love S. Oxidative stress in brain ischemia. Brain Pathol. 9:1999;119-131.
33. Love S., Barber R., Wilcock G.K. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol. Appl. Neurobiol. 25:1999;98-103.
34. Mabley J.G., Jagtap P., Perretti M., Getting S.J., Salzman A.L., Virag L., Szabo E., Soriano F.G., Liaudet L., Abdelkarim G.E., Hasko G., Marton A., Southan G.J., Szabo C. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm. Res. 50:2001;561-569.
35. Mazzon E., Serraino I., Li J.H., Dugo L., Caputi A.P., Zhang J., Cuzzocrea S. GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation. Eur. J. Pharmacol. 415:2001;85-94.
36. Oliver F.J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18:1999;4446-4454.
37. Paschen W., Olah L., Mies G. Effect of transient focal ischemia of mouse brain on energy state and NAD levels: no evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism. J. Neurochem. 75:2000;1675-1680.
38. Pieper A.A., Blackshaw S., Clements E.E., Brat D.J., Krug D.K., White A.J., Pinto-Garcia P., Favit A., Conover J.R., Snyder S.H., Verma A. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1845-1850.
39. Royo N.C., Wahl F., Stutzmann J.M. Kinetics of polymorphonuclear neutrophil infiltration after a traumatic brain injury in rat. Neuroreport. 10:1999;1363-1367.
40. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat. Res. 460:2000;1-15.
41. Sharp C., Warren A., Oshima T., Williams L., Li J.H., Alexander J.S. Poly ADP ribose-polymerase inhibitors prevent the upregulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. Inflammation. 25:2001;157-163.
42. Stevens S.L., Bao J., Hollis J., Lessov N.S., Clark W.M., Stenzel-Poore M.P. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res. 932:2002;110-119.
43. Suzuki M., Tabuchi M., Ikeda M., Tomita T. Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats. Brain Res. 951:2002;113-120.
44. Szabo C., Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19:1998;287-298.
45. Szabo C., Lim L.H., Cuzzocrea S., Getting S.J., Zingarelli B., Flower R.J., Salzman A.L., Perretti M. Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J. Exp. Med. 186:1997;1041-1049.
46. Takahashi K., Greenberg J.H. The effect of reperfusion on neuroprotection using an inhibitor of poly(ADP-ribose) polymerase. Neuroreport. 10:1999;2017-2022.
47. Takahashi K., Greenberg J.H., Jackson P., Maclin K., Zhang J. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17:1997;1137-1142.
48. Takahashi K., Pieper A.A., Croul S.E., Zhang J., Snyder S.H., Greenberg J.H. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829:1999;46-54.
49. Yang Z., Zingarelli B., Szabo C. Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock. 13:2000;60-66.
50. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:2002;259-263.
51. Zhang R.L., Chopp M., Chen H., Garcia J.H. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125:1994;3-10.
52. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc. Res. 36:1997;205-215.
53. Zingarelli B., Salzman A.L., Szabo C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83:1998;85-94.
54. Zingarelli B., Szabo C., Salzman A.L. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology. 116:1999;335-345.